Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
- PMID: 32292866
- PMCID: PMC7128395
- DOI: 10.1016/j.ekir.2020.04.001
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease (COVID-19), is a major pandemic challenging health care systems around the world. The optimal management of patients infected with COVID-19 is still unclear, although the consensus is moving toward the need of a biphasic approach. During the first phase of the disease (from onset of the symptoms up to 7-10 days) viral-induced effects are prominent, with the opportunity to institute antiviral therapy. In the second inflammatory phase of the disease, immunosuppressive strategies (for example with glucocorticoids or anticytokine drugs) may be considered. This latter stage is characterized by the development of progressive lung involvement with increasing oxygen requirements and occasionally signs of the hemophagocytic syndrome. The management of the disease in patients with kidney disease is even more challenging, especially in those who are immunosuppressed or with severe comorbidities. Here we present the therapeutic approach used in Brescia (Italy) for managing patients infected with COVID-19 who underwent kidney transplantation and are receiving hemodialysis. Furthermore, we provide some clinical and physiopathological background, as well as preliminary outcome data of our cohort, to better clarify the pathogenesis of the disease and clinical management.
Keywords: COVID-19; SARS-CoV-2; dialysis; kidneys; management; patients; transplant.
© 2020 International Society of Nephrology. Published by Elsevier Inc.
Comment in
-
Six Years of KI Reports: Milestones Behind and Ahead.Kidney Int Rep. 2021 Dec 6;7(1):1-2. doi: 10.1016/j.ekir.2021.11.030. eCollection 2022 Jan. Kidney Int Rep. 2021. PMID: 35005305 Free PMC article. No abstract available.
References
-
- The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Disease (COVID-19)—Chinese, 2020. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a.... Accessed March 22, 2020. - PMC - PubMed
-
- Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response [e-pub ahead of print. JAMA. https://doi.org/10.1001/jama.2020.4031. Accessed March 24, 2020. - DOI - PubMed
-
- Guidelines on the Therapeutic and Support Management of Patients with COVID-19 Coronavirus Infection. Edition 2.0, 12 March 2020. Available at: http://www.simit.org/medias/1568-covid19-vademecum-20.13.marzo.2020.pdf. Accessed March 22, 2020
-
- World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-ac.... Accessed March 22, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous